GURenal cancer Episode 8: Rechallenging with immune checkpoint inhibitors does not benefit mRCC patients after progression 11 March 2024
Breast Cancer Episode 18: Olaparib increases ORR in advanced cancers with BRCA1/2 but not CHEK2 and ATM mutations, the PRECISION 2 trial 7 March 2024
GI Episode 9: First data from CheckMate 8WH investigating double immunotherapy as a first line treatment in MSI-H/dMMR metastatic colon cancer 6 March 2024
GUUrothelial cancer Episode 7: Chemoradiotherapy emerges as a viable option for bladder sparing treatment in MIUC 4 March 2024
Breast Cancer Episode 17: Insights from the KATHERINE Trial: iDFS surrogate endpoint is predictive for OS in breast cancer patients 29 February 2024
GI Episode 8: Neo-adjuvant immunotherapy and pCR as a biomarker in G/GEJ cancer: insights from the KEYNOTE-585 + MATTERHORN study 28 February 2024
Lung Cancer Episode 5: KEYNOTE-671 demonstrates the OS benefit of perioperative immunochemotherapy in early-stage NSCLC 27 February 2024
Breast Cancer Episode 16: The NATALEE trial: ribociclib as a key adjuvant CDK4/6 Inhibitor for breast cancer 22 February 2024
